New anticoagulation method for ECMO patients
Treatments studied
This trial tests a way to manage blood clotting in patients on ECMO (a machine that helps breathe for very sick patients). It uses a drug called Nafamostat with a lower dose of standard blood thinners, which may reduce bleeding risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are receiving ECMO for severe breathing failure
- You do not have any conditions that prevent safe use of blood thinners
- You have not had a stroke (cerebral infarction) and are not suspected of having one
- You do not have severe high blood pressure
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a safe, backup ECMO machine for people with very weak hearts or complex blockages who need high-risk stenting. It helps keep your blood pumping if your heart struggles during the procedure.
This study tests whether adding a medicine called prostacyclin (which helps keep blood from clotting) to the standard blood thinner can help children on ECMO—a machine that takes over heart and lung function—have fewer clotting problems and bleeding issues.
This study looks at whether a blood test called D-dimer can help predict bleeding in patients on ECMO, a machine that helps the heart or lungs. It aims to improve safety by monitoring this marker.
This trial tests a medicine called nafamostat mesilate to prevent blood clots in patients who need ECMO (a machine that helps your heart and lungs) after heart surgery. It may offer a safer way to thin the blood compared to standard treatments.
This trial tests if bivalirudin is a safe and effective blood thinner for people on ECMO, a machine that helps your heart and lungs. You may be eligible if you need this therapy and have no past reactions to similar medicines.
This trial studies whether people on a breathing machine called VV-ECMO can be managed without routine blood thinners, to reduce bleeding risk. It is meant for adults with severe lung failure (ARDS) and checks that it is safe for you to avoid anticoagulation.
Hear when a new ECMO trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.